In this work, we compare lncRNA expression profiles in the clinical samples of AI-treated ER-positive breast cancer patients and identify DIO3OS as an important RNA regulator in reprograming glucose metabolism in AI-resistant breast tumors. The gene discussed is DIO3OS; the disease is breast neoplasm.